Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: BOIRON

Market Cap 49Cr 56Cr 45Cr 42Cr 79Cr 5.4TCr 81Cr 538.37Cr 208.44Cr 2.6TCr 211.8Cr 207.24Cr 9.05TCr P/E Ratio 2024
41x
P/E Ratio 2025 16.1x
Enterprise Value 44Cr 51Cr 41Cr 38Cr 71Cr 4.87TCr 73Cr 485.75Cr 188.07Cr 2.35TCr 191.1Cr 186.98Cr 8.17TCr EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-1.40%
1 week-0.35%
Current month-0.70%
1 month+1.08%
3 months+7.43%
6 months-6.00%
Current year-6.93%
1 week 28.1
Extreme 28.1
28.9
1 month 26.1
Extreme 26.1
29.5
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 56 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap.
29/23/29Sell 8,58,660 4.8939%
29/23/29Sell

Director

1,98,664 1.1323%
29/23/29Sell

Director

32,67,121 18.6209%
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%-0.35%+22.34%-26.18% 56Cr
+0.82%+4.01%-11.30%-3.81% 1.33TCr
-1.10%-2.21%-35.37%-56.82% 491.86Cr
-0.22%+2.94%-9.20%-2.82% 474.29Cr
-1.86%-5.35%+8.38%-21.79% 377.8Cr
-1.61%+0.40%+2.70%-43.28% 375.53Cr
-2.69%-4.14%-5.21%-10.76% 358.7Cr
-0.91%+1.00%-13.63%-5.90% 313.09Cr
-1.50%-2.43%-13.60%-32.08% 225.37Cr
-6.14%-3.41%-15.13%+24.40% 171.63Cr
Average -1.66%-1.89%-7.00%-17.90% 417.58Cr
Weighted average by Cap. -0.86%-0.51%-10.34%-16.54%

Financials

2024 2025
Net sales 49Cr 56Cr 45Cr 42Cr 79Cr 5.38TCr 80Cr 536.11Cr 207.56Cr 2.59TCr 210.91Cr 206.37Cr 9.02TCr 50Cr 58Cr 46Cr 43Cr 81Cr 5.53TCr 83Cr 551.01Cr 213.33Cr 2.67TCr 216.77Cr 212.1Cr 9.27TCr
Net income 1.13Cr 1.31Cr 1.04Cr 97.91L 1.83Cr 125.08Cr 1.87Cr 12Cr 4.83Cr 60Cr 4.9Cr 4.8Cr 209.64Cr 3.26Cr 3.76Cr 3.01Cr 2.82Cr 5.27Cr 360.18Cr 5.38Cr 36Cr 14Cr 173.62Cr 14Cr 14Cr 603.67Cr
Net Debt -4.97Cr -5.73Cr -4.58Cr -4.3Cr -8.03Cr -548.8Cr -8.19Cr -55Cr -21Cr -264.54Cr -22Cr -21Cr -919.8Cr -4.79Cr -5.51Cr -4.41Cr -4.13Cr -7.72Cr -528.02Cr -7.88Cr -53Cr -20Cr -254.52Cr -21Cr -20Cr -884.98Cr
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
11/26/11 28.20 -1.40% 1,932
10/26/10 28.60 -0.35% 1,911
09/26/09 28.70 +1.06% 1,734
08/26/08 28.40 -1.39% 1,981
05/26/05 28.80 +1.77% 3,521

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!